Aprepitant Versus Hydroxyzine in Persistent Aquagenic Pruritus for Patients With Myeloproliferative Neoplasms
Clinical trial NCT03808805 · COMPLETED
Trial details
- NCT number
- NCT03808805
- Sponsor
- University Hospital, Brest
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-16
- Primary completion
- 2023-09-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.